Planet 13 Holdings (PLNH) Times Interest Earned (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Times Interest Earned came in at -$0.05 in Q1 2026, up 98.56% year-on-year from -$0.03 in Q1 2025, and down 106.0% on a QoQ basis from $0.88 in Q4 2025.
Planet 13 Holdings (PLNH) Times Interest Earned (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Times Interest Earned data on file, last reported at -$0.05 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 98.56% year-over-year to -$0.05 in Q1 2026; TTM through Mar 2026 was -$0.54, a 92.05% increase from a year earlier, with the FY2025 full-year figure at -$0.91, up 26.68% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$0.05, down from $0.88 in the prior quarter.
- Over the last five years, Times Interest Earned for PLNH reached as high as $0.88 in Q4 2025 and fell as low as -$36.13 in Q4 2022.
- Historically, Times Interest Earned has averaged -$4.09 across 5 years, with a median of -$0.55 in 2023.
- Across the five-year window, Times Interest Earned slumped 71255.5% in 2022 and surged 106.28% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$36.13 in 2022, then surged by 76.11% to -$8.63 in 2023, then tumbled by 62.45% to -$14.02 in 2024, then jumped by 106.28% to $0.88 in 2025, then tumbled by 106.0% to -$0.05 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$0.05 in Q1 2026, $0.88 in Q4 2025, and -$0.62 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Dec 31, 2025 | 0.88 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.84 |
| Mar 31, 2025 | -3.68 |
| Dec 31, 2024 | -14.02 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.41 |
| Mar 31, 2024 | -3.70 |
| Dec 31, 2023 | -8.63 |
| Sep 30, 2023 | -0.55 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -1.02 |
| Dec 31, 2022 | -36.13 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.05 |
| Sep 30, 2021 | -0.29 |
| Jun 30, 2021 | -1.05 |